The Role of Breast Milk Cell-Free DNA in the Regulation of the Neonatal Immune Response

Overview

Journal Nutrients

Date 2025 Jan 8

PMID 39770994

Authors

Tamim Rezai

Shani Fell-Hakai

Shalini Guleria

Gergely Toldi

Affiliations

Soon will be listed here.

Abstract

The neonatal period is a critical phase for the development of the intestinal immune system, marked by rapid adaptation to the external environment and unique nutritional demands. Breast milk plays a pivotal role in this transition, yet the mechanisms by which it influences neonatal mucosal immunity remain unclear. This review examines the potential mechanisms by which cell-free DNA (cfDNA) in breast milk may impact neonatal immune development, particularly through Toll-like receptor 9 (TLR9) signalling and gut microbiota interactions. We propose that cfDNA in breast milk interacts with TLR9 on the apical surface of neonatal intestinal epithelial cells, potentially serving as an initial anti-inflammatory stimulus before the establishment of commensal bacteria. This hypothesis is supported by the high concentration and stability of cfDNA in breast milk, as well as the known activation of TLR9 by mitochondrial DNA in breast milk. The review emphasises the need for further empirical research to validate these interactions and their implications for neonatal health, suggesting that understanding these dynamics could lead to improved strategies for neonatal care and disease prevention.

Citing Articles

Disrupting and restoring protection: maternal antibiotic exposure and neonatal IgA transfer via breastfeeding.

Gasser O, Toldi G Pediatr Res. 2025; .

PMID: 40069482 DOI: 10.1038/s41390-025-03992-4.

Human Milk's Messengers from Mother to Infant.

Ramzan F, Toldi G Pediatr Res. 2025; .

PMID: 40021922 DOI: 10.1038/s41390-025-03973-7.

References

Lin P, Stoll B . Necrotising enterocolitis. Lancet. 2006; 368(9543):1271-83. DOI: 10.1016/S0140-6736(06)69525-1. View

Kalbermatter C, Fernandez Trigo N, Christensen S, Ganal-Vonarburg S . Maternal Microbiota, Early Life Colonization and Breast Milk Drive Immune Development in the Newborn. Front Immunol. 2021; 12:683022. PMC: 8158941. DOI: 10.3389/fimmu.2021.683022. View

Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H . A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408(6813):740-5. DOI: 10.1038/35047123. View

Ivanov M, Baranova A, Butler T, Spellman P, Mileyko V . Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation. BMC Genomics. 2015; 16 Suppl 13:S1. PMC: 4686799. DOI: 10.1186/1471-2164-16-S13-S1. View

Yan Y, Guo Q, Wang F, Adhikari R, Zhu Z, Zhang H . Cell-Free DNA: Hope and Potential Application in Cancer. Front Cell Dev Biol. 2021; 9:639233. PMC: 7938321. DOI: 10.3389/fcell.2021.639233. View

Rutz M, Metzger J, Gellert T, Luppa P, Lipford G, Wagner H . Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur J Immunol. 2004; 34(9):2541-50. DOI: 10.1002/eji.200425218. View

Sender R, Noor E, Milo R, Dor Y . What fraction of cellular DNA turnover becomes cfDNA?. Elife. 2024; 12. PMC: 10942627. DOI: 10.7554/eLife.89321. View

Bauer S, Kirschning C, Hacker H, Redecke V, Hausmann S, Akira S . Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A. 2001; 98(16):9237-42. PMC: 55404. DOI: 10.1073/pnas.161293498. View

Song Q, Zhang Y, Liu H, Du Y . Potential of Using Cell-Free DNA and miRNA in Breast Milk to Screen Early Breast Cancer. Biomed Res Int. 2020; 2020:8126176. PMC: 7354639. DOI: 10.1155/2020/8126176. View

10.

Lee J, Mo J, Katakura K, Alkalay I, Rucker A, Liu Y . Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol. 2006; 8(12):1327-36. DOI: 10.1038/ncb1500. View

11.

Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W . Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010; 464(7285):104-7. PMC: 2843437. DOI: 10.1038/nature08780. View

12.

Li Y, Berke I, Modis Y . DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature. EMBO J. 2012; 31(4):919-31. PMC: 3280545. DOI: 10.1038/emboj.2011.441. View

13.

Lamphier M, Sirois C, Verma A, Golenbock D, Latz E . TLR9 and the recognition of self and non-self nucleic acids. Ann N Y Acad Sci. 2006; 1082:31-43. DOI: 10.1196/annals.1348.005. View

14.

Poliseno L, Lanza M, Pandolfi P . Coding, or non-coding, that is the question. Cell Res. 2024; 34(9):609-629. PMC: 11369213. DOI: 10.1038/s41422-024-00975-8. View

15.

Levy O . Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007; 7(5):379-90. DOI: 10.1038/nri2075. View

16.

Lyons K, Ryan C, Dempsey E, Ross R, Stanton C . Breast Milk, a Source of Beneficial Microbes and Associated Benefits for Infant Health. Nutrients. 2020; 12(4). PMC: 7231147. DOI: 10.3390/nu12041039. View

17.

Gribar S, Sodhi C, Richardson W, Anand R, Gittes G, Branca M . Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis. J Immunol. 2008; 182(1):636-46. PMC: 3761063. DOI: 10.4049/jimmunol.182.1.636. View

18.

Saura C, Ortiz C, Matito J, Arenas E, Sunol A, Martin A . Early-Stage Breast Cancer Detection in Breast Milk. Cancer Discov. 2023; 13(10):2180-2191. PMC: 10551665. DOI: 10.1158/2159-8290.CD-22-1340. View

19.

Otte J, Cario E, Podolsky D . Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology. 2004; 126(4):1054-70. DOI: 10.1053/j.gastro.2004.01.007. View

20.

Shaw A, Sim K, Rose G, Wooldridge D, Li M, Misra R . Premature neonatal gut microbial community patterns supporting an epithelial TLR-mediated pathway for necrotizing enterocolitis. BMC Microbiol. 2021; 21(1):225. PMC: 8343889. DOI: 10.1186/s12866-021-02285-0. View